Gabapentin Enacarbil and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Gabapentin Enacarbil and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: gabapentin enacarbil
Brand name: Horizant
Synonyms: n.a.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Gabapentin Enacarbil-Insulin degludec
- Gabapentin Enacarbil-Insulin Degludec (U-100) Prefilled Pens
- Gabapentin Enacarbil-Insulin Degludec (U-100) Vials
- Gabapentin Enacarbil-Insulin Degludec (U-200) Prefilled Pens
- Gabapentin Enacarbil-Insulin degludec and liraglutide
- Gabapentin Enacarbil-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Gabapentin Oral Solution
- Insulin aspart, recombinant Subcutaneous-Gabapentin Tablets
- Insulin aspart, recombinant Subcutaneous-Gabapentin Tablets (PHN)
- Insulin aspart, recombinant Subcutaneous-Gabapentin Tablets 600 mg and 800 mg
- Insulin aspart, recombinant Subcutaneous-Gabarone
- Insulin aspart, recombinant Subcutaneous-Gabazolamine-0.5 Oral